REFERENCES
- Terlizzi V, Claut L, Tosco A, Colombo C, Raia V, Fabrizzi B, Lucarelli
M, Angeloni A, Cimino G, Castaldo A, et al. A survey of the
prevalence, management, and outcome of infants with an inconclusive
diagnosis following newborn bloodspot screening for cystic fibrosis
(CRMS/CFSPID) in six Italian centres. J Cyst Fibros . 2021;
20:828-834.
- Terlizzi V, Mergni G, Centrone C, Festini F, Taccetti G. Trend of
sweat chloride values in a cohort of patients carrying CFTR mutations
of varying clinical consequence: Is there a risk of increasing sweat
chloride over time? Pediatr Pulmonol . 2020; 55:1089-1093.
- Castaldo A, Cimbalo C, Castaldo RJ, D’Antonio M, Scorza M, Salvadori
L, Sepe A, Raia V, Tosco A. Cystic Fibrosis-Screening Positive
Inconclusive Diagnosis: Newborn Screening and Long-Term Follow-Up
Permits to Early Identify Patients with CFTR-Related Disorders.Diagnostics (Basel). 2020; 10:570.
- Tosco A, Castaldo A, Colombo C, Claut L, Carnovale V, Iacotucci P,
Lucarelli M, Cimino G, Fabrizzi B, Caporelli N, et al. Clinical
outcomes of a large cohort of individuals with the F508del/5T;TG12
CFTR genotype. J Cyst Fibros . 2022: S1569-1993(22)00109-6.
- Farrell PM, White TB, Ren CL, Hempstead SE, Accurso F, Derichs N,
Howenstine M, McColley SA, Rock M, Rosenfeld M, et al. Diagnosis of
Cystic Fibrosis: Consensus Guidelines from the Cystic Fibrosis
Foundation. J Pediatr 2017 181S:S4-S15.
- Bombieri C, Claustres M, De Boeck K, Derichs N, Dodge J, Girodon E,
Sermet I, Schwarz M, Tzetis M, Wilschanski M, et al. Recommendations
for the classification of diseases as CFTR-related disorders. J
Cyst Fibros 2011;10(Suppl 2):S86–102 .
Table 1: Age, genotypes, symptoms, sweat chloride values, and diagnosis
on 30 May 2021 of enrolled subjects